Stay updated on Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.

Latest updates to the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page
- Check4 days agoChange DetectedThe history now includes a new entry Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedNew Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the history, indicating a backend/template update rather than changes to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe site-wide funding status notice was removed. Study history content and page navigation remain unchanged.SummaryDifference0.4%

- Check54 days agoChange DetectedA new version entry (Version 41, 2025-02-28) was added to the Record History, updating recruitment status, study status, study design, outcome measures, and locations.SummaryDifference0.1%

- Check83 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference10%

- Check90 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%

Stay in the know with updates to Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.